Tsumura & Co. (4540.T)
JPY 4759.0
(-0.69%)
JPY 4759.0
(-0.69%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 132.88 Billion JPY | 6.68% |
| 2022 | 124.56 Billion JPY | 34.13% |
| 2021 | 92.87 Billion JPY | 8.12% |
| 2020 | 85.89 Billion JPY | -12.35% |
| 2019 | 97.99 Billion JPY | 20.71% |
| 2018 | 81.18 Billion JPY | -16.45% |
| 2017 | 97.16 Billion JPY | 50.39% |
| 2016 | 64.61 Billion JPY | -3.23% |
| 2015 | 66.76 Billion JPY | 3.18% |
| 2014 | 64.7 Billion JPY | 19.15% |
| 2013 | 54.3 Billion JPY | 4.58% |
| 2012 | 51.92 Billion JPY | 4.62% |
| 2011 | 49.63 Billion JPY | -1.51% |
| 2010 | 50.39 Billion JPY | -1.08% |
| 2009 | 50.94 Billion JPY | -3.62% |
| 2008 | 52.85 Billion JPY | -15.75% |
| 2007 | 62.73 Billion JPY | -14.95% |
| 2006 | 73.76 Billion JPY | -8.41% |
| 2005 | 80.53 Billion JPY | -3.96% |
| 2004 | 83.85 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 137.61 Billion JPY | 3.56% |
| 2023 Q4 | 132.88 Billion JPY | 9.69% |
| 2023 FY | 132.88 Billion JPY | 6.68% |
| 2023 Q3 | 121.14 Billion JPY | -5.3% |
| 2023 Q2 | 127.92 Billion JPY | 1.25% |
| 2023 Q1 | 126.34 Billion JPY | 1.43% |
| 2022 FY | 124.56 Billion JPY | 34.13% |
| 2022 Q1 | 93.51 Billion JPY | 0.69% |
| 2022 Q3 | 121.27 Billion JPY | -2.69% |
| 2022 Q2 | 124.62 Billion JPY | 33.27% |
| 2022 Q4 | 124.56 Billion JPY | 2.71% |
| 2021 Q2 | 90.24 Billion JPY | 3.7% |
| 2021 FY | 92.87 Billion JPY | 8.12% |
| 2021 Q4 | 92.87 Billion JPY | 4.41% |
| 2021 Q1 | 87.01 Billion JPY | 1.31% |
| 2021 Q3 | 88.94 Billion JPY | -1.43% |
| 2020 Q3 | 85.35 Billion JPY | 1.02% |
| 2020 Q2 | 84.49 Billion JPY | -15.74% |
| 2020 FY | 85.89 Billion JPY | -12.35% |
| 2020 Q1 | 100.26 Billion JPY | 2.32% |
| 2020 Q4 | 85.89 Billion JPY | 0.63% |
| 2019 Q3 | 77.72 Billion JPY | -3.05% |
| 2019 FY | 97.99 Billion JPY | 20.71% |
| 2019 Q1 | 81.97 Billion JPY | 0.98% |
| 2019 Q4 | 97.99 Billion JPY | 26.08% |
| 2019 Q2 | 80.17 Billion JPY | -2.2% |
| 2018 FY | 81.18 Billion JPY | -16.45% |
| 2018 Q4 | 81.18 Billion JPY | 6.54% |
| 2018 Q3 | 76.19 Billion JPY | -1.81% |
| 2018 Q2 | 77.59 Billion JPY | -4.81% |
| 2018 Q1 | 81.52 Billion JPY | -16.1% |
| 2017 FY | 97.16 Billion JPY | 50.39% |
| 2017 Q1 | 96.87 Billion JPY | 49.94% |
| 2017 Q2 | 96.01 Billion JPY | -0.89% |
| 2017 Q4 | 97.16 Billion JPY | 4.85% |
| 2017 Q3 | 92.67 Billion JPY | -3.48% |
| 2016 Q1 | 65.24 Billion JPY | -2.28% |
| 2016 FY | 64.61 Billion JPY | -3.23% |
| 2016 Q3 | 62.63 Billion JPY | -3.92% |
| 2016 Q4 | 64.61 Billion JPY | 3.16% |
| 2016 Q2 | 65.18 Billion JPY | -0.1% |
| 2015 Q2 | 63.41 Billion JPY | -8.09% |
| 2015 FY | 66.76 Billion JPY | 3.18% |
| 2015 Q1 | 68.99 Billion JPY | 6.62% |
| 2015 Q3 | 65 Billion JPY | 2.51% |
| 2015 Q4 | 66.76 Billion JPY | 2.71% |
| 2014 FY | 64.7 Billion JPY | 19.15% |
| 2014 Q4 | 64.7 Billion JPY | -0.32% |
| 2014 Q3 | 64.91 Billion JPY | 0.52% |
| 2014 Q2 | 64.58 Billion JPY | -3.49% |
| 2014 Q1 | 66.91 Billion JPY | 23.23% |
| 2013 Q3 | 51.47 Billion JPY | -0.2% |
| 2013 Q4 | 54.3 Billion JPY | 5.5% |
| 2013 FY | 54.3 Billion JPY | 4.58% |
| 2013 Q2 | 51.57 Billion JPY | -2.65% |
| 2013 Q1 | 52.97 Billion JPY | 2.02% |
| 2012 Q3 | 47.1 Billion JPY | -2.91% |
| 2012 Q4 | 51.92 Billion JPY | 10.24% |
| 2012 Q1 | 49.06 Billion JPY | -1.15% |
| 2012 Q2 | 48.51 Billion JPY | -1.11% |
| 2012 FY | 51.92 Billion JPY | 4.62% |
| 2011 Q3 | 46.29 Billion JPY | -6.26% |
| 2011 FY | 49.63 Billion JPY | -1.51% |
| 2011 Q1 | 50.63 Billion JPY | 0.47% |
| 2011 Q2 | 49.38 Billion JPY | -2.47% |
| 2011 Q4 | 49.63 Billion JPY | 7.22% |
| 2010 Q2 | 48.41 Billion JPY | -2.14% |
| 2010 Q1 | 49.47 Billion JPY | -2.89% |
| 2010 FY | 50.39 Billion JPY | -1.08% |
| 2010 Q4 | 50.39 Billion JPY | 5.12% |
| 2010 Q3 | 47.94 Billion JPY | -0.97% |
| 2009 Q4 | 50.94 Billion JPY | 4.75% |
| 2009 Q2 | 50.75 Billion JPY | 0.0% |
| 2009 Q3 | 48.63 Billion JPY | -4.18% |
| 2009 FY | 50.94 Billion JPY | -3.62% |
| 2008 Q3 | 51.67 Billion JPY | 0.0% |
| 2008 FY | 52.85 Billion JPY | -15.75% |
| 2008 Q4 | 52.85 Billion JPY | 2.29% |
| 2007 FY | 62.73 Billion JPY | -14.95% |
| 2006 FY | 73.76 Billion JPY | -8.41% |
| 2005 FY | 80.53 Billion JPY | -3.96% |
| 2004 FY | 83.85 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -431.799% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 98.304% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 82.314% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | 19.146% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -3814.192% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | -209.989% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -376.875% |
| Eisai Co., Ltd. | 494.82 Billion JPY | 73.145% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -2536.627% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | -115.395% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -331.0% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | -233.935% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | -327.506% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | -233.96% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -899.368% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | 51.635% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | -200.933% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | -87.945% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | -183.381% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -1797.558% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -422.371% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -1532.078% |
| MedRx Co., Ltd | 129 Million JPY | -102912.403% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -3960.644% |
| Solasia Pharma K.K. | 673 Million JPY | -19645.319% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -20486.426% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | -323.46% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | 18.969% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -13039.597% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | 74.639% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -1811.386% |